Transfusion Medicine

Zhejiang Hospital's Department of Transfusion Medicine was established in July 2019 and currently has a total of 10 medical and technical staff across its two campuses, including 4 with master's degrees and 5 with bachelor's degrees; in terms of professional titles, 3 have senior titles and 3 have intermediate titles. The department's core responsibilities cover two major areas: ensuring the safety of clinical blood use at both campuses and laboratory testing related to clinical blood use: laboratory testing items include blood group serology, irregular antibody screening, blood viscosity, thromboelastography, platelet antibodies, Rh typing, blood group serology in pregnant women, screening for hemolytic disease of the newborn, identification of difficult blood groups, and compatibility testing in difficult cases, among others; transfusion therapy services include platelet-rich plasma (PRP) therapy, therapeutic removal of pathological blood components, and blood exchange therapy, among others; in addition, the department is also responsible for clinical blood safety management activities, including blood receipt, distribution, and storage, audits of appropriate clinical blood use, consultations on difficult transfusion cases, and analysis of adverse transfusion reactions.